Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-328805
Filing Date
2025-12-22
Accepted
2025-12-22 16:28:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d35579d424b3.htm 424B3 125495
2 GRAPHIC g35579g01a03.jpg GRAPHIC 48489
  Complete submission text file 0001193125-25-328805.txt   184439
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-292151 | Film No.: 251592821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)